Life AI Net
首页
资讯库
计算器
目录
登录
EN
Auto
首页
资讯库
计算器
目录
English
Auto
登录
首页
资讯库
计算器
目录
More
滚动资讯
FierceBiotech
Small pools, big ideas: How the rare disease community is reimagining clinical trials
Brady Corporation
Brady India Champions a New Era of Industrial Safety at Safety Conclave 2026 - Machine Maker
Thermo Fisher
Lobbying Update: $710,000 of THERMO FISHER SCIENTIFIC INC lobbying was just disclosed - Quiver Quantitative
10x Genomics Blog
Saxonov, 10x Genomics CEO, sells $122k in stock - Investing.com
10x Genomics Blog
Saxonov, 10x Genomics CEO, sells $122k in stock - Investing.com
10x Genomics Blog
10x Genomics (NASDAQ: TXG) CEO sells 5,000 shares in 10b5-1 trade - Stock Titan
FierceBiotech
RyghtAI launches clinical site search engine to aid drug developers, CROs with trial design
BioWorld
Sex differences shape gene activity across the human brain
FierceBiotech
Rare Disease Research, myTomorrows team up to help patients access trials
FierceBiotech
Aligos sells China rights to HBV drug to hepatology player Amoytop in $445M deal
FierceBiotech
Pfizer–backed Storm blows into $56M series C, launches phase 2 sarcoma trial
FierceBiotech
Johnson & Johnson hands back failed eye disease gene therapy to MeiraGTx
FierceBiotech
Small pools, big ideas: How the rare disease community is reimagining clinical trials
Brady Corporation
Brady India Champions a New Era of Industrial Safety at Safety Conclave 2026 - Machine Maker
Thermo Fisher
Lobbying Update: $710,000 of THERMO FISHER SCIENTIFIC INC lobbying was just disclosed - Quiver Quantitative
10x Genomics Blog
Saxonov, 10x Genomics CEO, sells $122k in stock - Investing.com
10x Genomics Blog
Saxonov, 10x Genomics CEO, sells $122k in stock - Investing.com
10x Genomics Blog
10x Genomics (NASDAQ: TXG) CEO sells 5,000 shares in 10b5-1 trade - Stock Titan
FierceBiotech
RyghtAI launches clinical site search engine to aid drug developers, CROs with trial design
BioWorld
Sex differences shape gene activity across the human brain
FierceBiotech
Rare Disease Research, myTomorrows team up to help patients access trials
FierceBiotech
Aligos sells China rights to HBV drug to hepatology player Amoytop in $445M deal
FierceBiotech
Pfizer–backed Storm blows into $56M series C, launches phase 2 sarcoma trial
FierceBiotech
Johnson & Johnson hands back failed eye disease gene therapy to MeiraGTx
资讯库
搜索
搜索
最新
最旧
清除
#Procurement Magazine
总数
1
主题
Procurement Magazine
搜索
BIOBASE
Cytiva (Google News)
2025年11月24日
可持续性:Cytiva实验室设备中的生物基树脂应用——采购杂志
#Cytiva Biobased
#Biobased Resins